Moleculin Biotech (MBRX) has issued an update.
Moleculin Biotech, Inc. is presenting its corporate presentation on its website on May 7, 2024, offering a glimpse into the company’s current status and future plans. This information, while informative for investors and those following the biotech industry, is not intended for official filing purposes under the Securities Exchange Act or for incorporation into future securities filings.
For a thorough assessment of MBRX stock, go to TipRanks’ Stock Analysis page.
